A postoperative patient with pH 7.25, MAP (mean arterial pressure) 60 mm Hg is treated with?
A patient is brought to the emergency department as a case of polytrauma following a head-on collision road traffic accident. His blood pressure is 90/60 mmHg, and tachycardia is present. What is the most likely diagnosis?
One of the most important complication of tracheostomy is:
Which of the following intravenous anaesthetic agent causes decrease in postoperative nausea and vomiting :
Which of the following is the FIRST-LINE antiemetic drug most commonly used for post-operative nausea and vomiting (PONV) prophylaxis?
Problems which may result from hypotensive anesthesia include:
Which of the following agents is used for the treatment of post operative shivering?
Most common post-operative complication of spinal anesthesia?
A patient with multiple gallstones shows 8 mm dilation and has 4 stones in the common bile duct (CBD). What is the best treatment modality?
What causes sudden decreased end tidal CO2 in GA?
Explanation: ***Fluid therapy with CVP monitoring*** - The patient's **MAP of 60 mmHg** indicates **hypotension** and potential **hypovolemic shock**, while pH 7.25 suggests **acidosis**, which could be metabolic due to poor perfusion. Initial treatment should focus on **restoring circulating volume** to improve blood pressure and organ perfusion. - **Central venous pressure (CVP) monitoring** is crucial to guide fluid resuscitation. It helps assess the patient's fluid status and ensures that enough fluid is given to improve cardiac output without causing fluid overload, especially in a severely ill patient. *Only normal saline* - While normal saline is used for fluid resuscitation, simply stating "only normal saline" is insufficient because it doesn't address the **critical need for monitoring** to guide treatment. - The amount and rate of fluid administration need to be carefully controlled based on the patient's response and hemodynamic parameters. *Fluid restriction* - **Fluid restriction** would be contraindicated in this patient because the **low MAP** suggests **hypovolemia or cardiogenic shock**, requiring fluid repletion, not restriction. - Restricting fluids could further worsen hypotension and organ hypoperfusion, leading to increased acidosis and organ damage. *I.V. sodium bicarbonate* - Administering **I.V. sodium bicarbonate** to correct acidosis without addressing the underlying cause of hypotension and poor perfusion is generally not recommended. - The acidosis (pH 7.25) is likely due to **poor tissue oxygenation and lactic acid production** from inadequate blood flow; correcting this with fluids will resolve the acidosis.
Explanation: ***Intraabdominal bleed*** - A patient with **polytrauma**, **hypotension**, and **tachycardia** following a head-on collision is highly suggestive of significant blood loss. - An **intraabdominal bleed** is a common cause of hypovolemic shock in blunt trauma, where a large volume of blood can accumulate without external signs. *EDH* - **Epidural hematomas (EDH)** typically present with a "lucid interval" and progressive neurological deficits, not immediate systemic hypotension. - While EDH is a serious head injury, it does not typically cause the degree of **hypotension** seen here. *SDH* - **Subdural hematomas (SDH)** are also head injuries causing neurological symptoms, which can be acute or chronic. - SDH alone, particularly in the acute phase, rarely leads to **profound hypovolemic shock** as described. *Intracranial hemorrhage* - While significant **intracranial hemorrhage** can cause neurological deterioration, it is a rare cause of systemic **hypotension** in adults. - Unless accompanied by significant brainstem compression leading to autonomic dysfunction, the blood volume lost within the cranium is usually insufficient to cause **hypovolemic shock**.
Explanation: ***Displacement of tube*** - **Accidental decannulation** or displacement of the tracheostomy tube is considered one of the most serious and common complications, particularly in the immediate post-operative period. - This can lead to **loss of airway**, requiring immediate intervention to prevent severe hypoxia and potential brain injury or death. *Hemorrhage* - While hemorrhage can occur during or after tracheostomy, it is often a concern during the procedure or in the immediate postoperative period and is usually managed effectively. - Significant, life-threatening hemorrhage such as **tracheo-innominate fistula** is a rare but severe complication. *Surgical emphysema* - Surgical emphysema (subcutaneous emphysema) is a relatively common but usually benign complication that occurs when air leaks from the trachea into the subcutaneous tissues. - It typically resolves spontaneously and rarely poses a direct threat to the airway unless severe and rapidly progressive. *Recurrent laryngeal nerve palsy* - **Recurrent laryngeal nerve injury** is a rare complication of tracheostomy, as the nerve is usually well clear of the incision site in the neck. - While it can cause hoarseness or vocal cord paralysis, it typically does not present an immediate life-threatening situation or emergency comparable to airway compromise.
Explanation: ***Propofol*** - **Propofol** has antiemetic properties, which contributes to a reduced incidence of **postoperative nausea and vomiting (PONV)**. - Its mechanism of action in reducing PONV is thought to involve effects on **dopaminergic receptors** and **serotonin pathways** in the brain. *Etomidate* - **Etomidate** is not known to significantly reduce PONV and may even have a neutral effect or slightly increase it compared to propofol. - Its primary advantages include **cardiovascular stability**, which is unrelated to antiemetic effects. *Ketamine* - **Ketamine** is associated with a higher incidence of PONV, especially at higher doses, due to its **psychedelic side effects** and stimulation of the chemoreceptor trigger zone. - It is known for causing **emergence delirium** and does not possess antiemetic properties. *Thiopentone* - **Thiopentone** (Thiopental) does not have any significant antiemetic properties and is not typically used for its effect on PONV. - It was historically used as an induction agent but has largely been replaced by newer drugs like propofol.
Explanation: ***Ondansetron*** - **Ondansetron** is a **5-HT3 receptor antagonist** and is considered a first-line agent due to its high efficacy and favorable side effect profile in preventing PONV. - It works by blocking serotonin receptors in the **chemoreceptor trigger zone** and the **gastrointestinal tract**, reducing the sensation of nausea and vomiting. *Lorazepam* - **Lorazepam** is a **benzodiazepine** primarily used for its **anxiolytic** and **sedative effects**, and sometimes as an adjunct for refractory nausea, but not as a first-line antiemetic for PONV prophylaxis. - While it can help indirectly by reducing anxiety, it does not directly target the key pathways involved in PONV as effectively as 5-HT3 antagonists. *Phenytoin* - **Phenytoin** is an **anticonvulsant** medication used to prevent seizures and has no role in the direct treatment or prophylaxis of PONV. - It primarily acts on voltage-gated sodium channels in neurons and does not possess antiemetic properties. *Metoclopramide* - **Metoclopramide** is a **dopamine D2 receptor antagonist** and a **prokinetic agent** that can be used for PONV, particularly when gastric stasis is a concern. - However, it is generally considered a second-line agent due to the risk of **extrapyramidal side effects**, especially with higher doses or prolonged use. *Promethazine* - **Promethazine** is a **first-generation antihistamine** with **antidopaminergic** and **anticholinergic properties** that can be effective for nausea and vomiting. - It is often used as a rescue antiemetic or in combination therapy, but its sedative effects and potential for extrapyramidal symptoms make it less preferable as a first-line prophylactic agent compared to ondansetron.
Explanation: ***All of the options*** - Hypotensive anesthesia is a technique used to reduce **blood pressure** during surgery, aiming to decrease **blood loss** and improve the **surgical field visibility**. - While beneficial, it carries inherent risks including **deep vein thrombosis (DVT), reactionary hemorrhage**, and complications like **retraction anemia** if not managed properly. *Deep vein thrombosis (DVT)* - While hypotension might seem to reduce the risk by lowering **blood flow velocity**, prolonged immobility and potential for **venous stasis** during any surgery, especially under hypotension, can increase DVT risk. - The combination of **endothelial dysfunction** and **hypercoagulability** often seen in surgical patients, coupled with reduced peripheral blood flow due to hypotension, can contribute to DVT formation. *Reactionary hemorrhage* - This is a common post-operative complication where bleeding restarts hours after surgery. With hypotensive anesthesia, **blood vessels** are constricted and may not be actively bleeding during the surgery. - As the patient's **blood pressure** returns to normal post-operatively, these previously undetected bleeds can manifest as significant **hemorrhage** due to the increased pressure. *Retraction anemia* - This term is less commonly used in medical literature. However, it likely refers to the complications arising from prolonged tissue retraction during surgery, which, when combined with reduced **perfusion** from hypotensive anesthesia, can lead to **tissue ischemia** or damage akin to anemia in the affected area. - The reduced **oxygen delivery** to tissues during hypotensive states, especially when further compromised by retraction, may result in localized tissue injury or contribute to systemic complications if severe or prolonged.
Explanation: ***Pethidine*** - **Pethidine (meperidine)** is a **synthetic opioid** known for its **mu-receptor agonism** and weak anticholinergic properties, making it effective in treating **post-operative shivering**. - Its mechanism in reducing shivering is thought to involve modulation of the **thermoregulatory center** in the hypothalamus. *Atropine* - **Atropine** is an **anticholinergic drug** that primarily blocks muscarinic acetylcholine receptors, leading to effects like increased heart rate and decreased secretions. - It does not directly act on the thermoregulatory centers or muscle activity responsible for shivering. *Thiopentone* - **Thiopentone** is a **barbiturate** used as an intravenous anesthetic, primarily for induction of anesthesia. - While it has CNS depressant effects, it is not indicated or effective for the specific treatment of post-operative shivering. *Suxamethonium* - **Suxamethonium (succinylcholine)** is a **depolarizing neuromuscular blocker** used to induce muscle paralysis, typically for intubation. - It would prevent shivering by paralyzing skeletal muscles, but this is a dangerous and inappropriate treatment for shivering due to its profound respiratory depressant effects.
Explanation: ***Hypotension due to spinal anesthesia*** - **Hypotension** is the **most common** immediate complication of spinal anesthesia due to **sympathetic blockade**, leading to **vasodilation** and decreased venous return. - This effect is often dose-dependent and can be managed with fluids and vasopressors if clinically significant. *Post-dural puncture headache* - While a notable complication, a **post-dural puncture headache (PDPH)** is less common than hypotension, occurring in a smaller percentage of spinal anesthesia cases. - PDPH results from persistent leakage of **cerebrospinal fluid** through the dural puncture site, leading to intracranial hypotension. *Urinary retention post-anesthesia* - **Urinary retention** is a relatively common complication after spinal anesthesia, but it is typically not as immediate or frequent as hypotension. - It occurs due to the **blockade of sacral parasympathetic nerves** that control bladder function, requiring temporary catheterization in some cases. *Infection leading to meningitis* - **Meningitis** is a **rare but severe** complication of spinal anesthesia, usually resulting from inadequate aseptic technique during the procedure. - Its incidence is very low compared to hemodynamic changes or even PDPH.
Explanation: ***ERCP followed by cholecystectomy*** - This is the **current standard of care** for managing choledocholithiasis with cholecystolithiasis - **ERCP with sphincterotomy** effectively clears CBD stones with success rates >90% - Followed by **laparoscopic cholecystectomy** (either during same admission or within 2 weeks) - This approach is **minimally invasive**, has lower morbidity, and shorter hospital stay compared to open surgery - Pre-operative ERCP is preferred when CBD stones are confirmed pre-operatively *Cholecystectomy with choledocholithotomy at the same setting* - This represents **open surgical approach** which is now largely **outdated** - Reserved only for cases where ERCP fails or is unavailable - Associated with higher morbidity, longer recovery, and larger incisions - **Laparoscopic CBD exploration** is preferred over open approach if surgical clearance is needed *ESWL (Extracorporeal Shock Wave Lithotripsy)* - ESWL is **not indicated for CBD stones** - Primarily used for **kidney stones** and occasionally for large gallbladder stones - CBD stones require endoscopic or surgical removal - Risk of stone fragments causing obstruction or pancreatitis *None of the options* - ERCP followed by cholecystectomy is the appropriate modern management - This option is not applicable as a correct option exists
Explanation: ***Cardiac arrest*** - In **cardiac arrest**, there is a sudden cessation of effective **cardiac output**, which leads to a dramatic reduction in pulmonary blood flow. - As a result, **CO2 is not transported to the lungs** for exhalation, causing an abrupt and severe drop in **end-tidal CO2**. *Pulmonary embolism* - A **pulmonary embolism** causes an acute obstruction of pulmonary arterial blood flow, leading to an **increase in alveolar dead space**. - While it can decrease **end-tidal CO2** due to reduced perfusion, the drop is often less sudden and complete than in cardiac arrest, and the primary mechanism is **ventilation-perfusion mismatch**. *Pulmonary hypertension* - **Pulmonary hypertension** involves chronically elevated pressures in the pulmonary arteries, which can lead to **right ventricular dysfunction** and reduced cardiac output over time. - It typically causes a more gradual and chronic reduction in **end-tidal CO2** due to impaired gas exchange, rather than a sudden, precipitous drop. *Malignant hyperthermia* - **Malignant hyperthermia** is characterized by a rapid and severe increase in **metabolic rate** and CO2 production. - This condition typically leads to a **sudden increase in end-tidal CO2** as the body produces more CO2 than can be eliminated, rather than a decrease.
Get full access to all questions, explanations, and performance tracking.
Start For Free